Angiotensin-converting enzyme inhibitor ACEI

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers decrease protein excretion and are the drugs of choice for hypertension in patients with CKD. 

Angiotensin-converting enzyme inhibitor (ACEI) to patients with CAD and diabetes or LV dysfunction... 

Exposure after this point may result in growth retardation, CNS or other abnormalities, or death (e.g., nonsteroidal antiinflammatory drugs [NSAIDs], angiotensin-converting enzyme inhibitors [ACEIs], and tetracycline derivatives). 

Antihypertensive therapy should be initiated in diabetic or nondiabetic CKD patients with an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker. Nondihydropyridine calcium channel blockers are generally used as second-line antiproteinuric drugs when ACEIs or angiotensin II receptor blockers are not tolerated. 

Pharmacology The angiotensin-converting enzyme inhibitors (ACEIs) appear to act... 

Longitudinal assessment of kidney function is important for monitoringtheefficacy of therapeutic interventions, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers, that are intended to slow the progression of kidney disease. 

No adverse interactions have been reported in patients treated with lithium and P-adrenoreceptor antagonists, whereas methyidopa has been reported to induce neurotoxic symptoms in some lithium-treated patients.There is a risk of lithium intoxication with simultaneous administration of angiotensin-converting enzyme inhibitors (ACEIs) lithium clearance may be reduced by up to 25%. ° Losartan, an angiotensin II antagonist, was anecdotally reported to induce lithium intoxication. ... 

Clinicaltrials.gov. Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications (PASS), Qntario, Canada 2010. ... 

Cyanohydrins are bifunctional molecules and therefore constitute a particularly useful class of compounds for synthetic purposes. A hydroxyl and a nitrile functional group are available for chemical and enzymatic follow-up reactions (Scheme 25.2 [7, 93-95]), resulting in hydroxy carboxylic acids [96-99], carbamates [KXl], hydroxy-amides [101], primary and secondary hydroxyamines [46,102-104], aziridines [105, 106], aminonitriles [107, 108], diamines [108], azidonitriles [108], a-fluoronitriles [109], hydroxy ketones [110], and many more. The (S)-selective H HNL and the (R)-selective PaHNL, in particular are used on large scale either for the s)mthesis of (S)-3-phenoxybenzaldehyde cyanohydrin, a precursor for p5U ethroids, a class of insecticides (R)- and (S)-mandelonitrile, which can be further converted to man-delic acids (R)-chloromandelonitrile, a precursor for an anticoagulant (R)-2-hydroxy-4-phenylbutyronitrile, which serves as intermediate for the production of angiotensin-converting enzyme inhibitors (ACEi) or (R)-2-amino-l-(2-furyl)ethanol [94]. Several HNLs are commercially available as free or immobilized enzymes. 

---